Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Urgent and emergency care

Pharmacy urgent medicine supply service extended by a further six months

Steve Brine, the pharmacy minister, has said that the NHS Urgent Medicine Supply Advanced Service pilot will now run until the end of March 2019.

steve brine

Source: Wikipedia / Chris McAndrew

Steve Brine has provided written confirmation that the NUMSAS pilot will be extended for another six months, stating that if it did not exist, almost 20% of patients who used the service would otherwise turn to urgent care services such as A&E

The NHS Urgent Medicine Supply Advanced Service (NUMSAS) has been extended for a further six months, the pharmacy minister Steve Brine has confirmed.

In a written Parliamentary answer, Brine said the service will run until the end of March 2019, although it will still exist only in pilot form.

NUMSAS, which provides a community pharmacy emergency supply service via NHS 111, was phased in from December 2016 using money from the Pharmacy Integration Fund.

It was due to end in March 2018 but, in November 2017 NHS England announced that the scheme would be extended for six months, until September 2018, to allow for a “proper evaluation”.

In his response to a Parliamentary question from former Conservative Party chair, Grant Shapps, Brine said that internal NHS figures showed that 19.2% of patients who used the urgent medicine service would otherwise use an urgent care centre, such as A&E, if the NUMSAS scheme did not otherwise exist.

The NUMSAS scheme is voluntary for pharmacies to register, and The Pharmaceutical Journal understands that figures from June 2018 show that around 4,000 pharmacies had signed up to provide the NUMSAS service.

In July 2018 The Pharmaceutical Journal revealed that April 2018 data showed that 2.5% of all calls to NHS 111 were referred to pharmacy, compared with less than 1% in April 2015.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205425

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • steve brine

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.